Ren H - Search Results

1

Transcriptome sequencing identified hub genes for hepatocellular carcinoma by weighted-gene co-expression analysis.

Pan Q, Long X, Song L, Zhao D, Li X, Li D, Li M, Zhou J, Tang X, Ren H, Ding K. Pan Q, et al. Among authors: ren h. Oncotarget. 2016 Jun 21;7(25):38487-38499. doi: 10.18632/oncotarget.9555. Oncotarget. 2016. PMID: 27220887 Free PMC article.

2

A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma.

Lan YH, Li YG, Liang ZW, Chen M, Peng ML, Tang L, Hu HD, Ren H. Lan YH, et al. Among authors: ren h. Cancer Immunol Immunother. 2007 Jul;56(7):1009-16. doi: 10.1007/s00262-006-0254-3. Epub 2006 Dec 22. Cancer Immunol Immunother. 2007. PMID: 17186291 Free PMC article.

3

Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.

Hu P, Hu HD, Chen M, Peng ML, Tang L, Tang KF, Matsui M, Belladonna ML, Yoshimoto T, Zhang DZ, Xiang R, Ren H. Hu P, et al. Among authors: ren h. Mol Immunol. 2009 May;46(8-9):1654-62. doi: 10.1016/j.molimm.2009.02.025. Epub 2009 Mar 18. Mol Immunol. 2009. PMID: 19299021

4

Down-regulation of Dicer in hepatocellular carcinoma.

Wu JF, Shen W, Liu NZ, Zeng GL, Yang M, Zuo GQ, Gan XN, Ren H, Tang KF. Wu JF, et al. Among authors: ren h. Med Oncol. 2011 Sep;28(3):804-9. doi: 10.1007/s12032-010-9520-5. Epub 2010 Apr 20. Med Oncol. 2011. PMID: 20405249

5

Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.

Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou F, Shan X, Cai X, Chen Q, Ling N, Zhang B, Bi Y, Chen K, Ren H, Huang A, He TC, Tang N. Liu J, et al. Among authors: ren h. PLoS One. 2011;6(11):e27496. doi: 10.1371/journal.pone.0027496. Epub 2011 Nov 15. PLoS One. 2011. PMID: 22110662 Free PMC article.

6

Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line.

Tong SW, Yang YX, Hu HD, An X, Ye F, Hu P, Ren H, Li SL, Zhang DZ. Tong SW, et al. Among authors: ren h. J Cell Biochem. 2012 May;113(5):1671-80. doi: 10.1002/jcb.24036. J Cell Biochem. 2012. PMID: 22189913

7

The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.

Liu Y, Wang X, Li S, Hu H, Zhang D, Hu P, Yang Y, Ren H. Liu Y, et al. Among authors: ren h. J Proteomics. 2014 Jun 25;106:99-112. doi: 10.1016/j.jprot.2014.04.021. Epub 2014 Apr 24. J Proteomics. 2014. PMID: 24769235

8

Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.

Hu H, Ding X, Yang Y, Zhang H, Li H, Tong S, An X, Zhong Q, Liu X, Ma L, Liu Q, Liu B, Lu Z, Zhang D, Hu P, Ren H. Hu H, et al. Among authors: ren h. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 15;307(6):G611-22. doi: 10.1152/ajpgi.00160.2014. Epub 2014 Jul 3. Am J Physiol Gastrointest Liver Physiol. 2014. PMID: 24994855 Free article.

9

C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma.

She S, Xiang Y, Yang M, Ding X, Liu X, Ma L, Liu Q, Liu B, Lu Z, Li S, Liu Y, Ran X, Xu X, Hu H, Hu P, Zhang D, Ren H, Yang Y. She S, et al. Among authors: ren h. Int J Oncol. 2015 Aug;47(2):543-54. doi: 10.3892/ijo.2015.3042. Epub 2015 Jun 10. Int J Oncol. 2015. PMID: 26058824

10

A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines.

Xiang Y, Liu Y, Yang Y, Hu H, Hu P, Ren H, Zhang D. Xiang Y, et al. Among authors: ren h. Oncol Rep. 2015 Sep;34(3):1249-60. doi: 10.3892/or.2015.4106. Epub 2015 Jul 3. Oncol Rep. 2015. PMID: 26151126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,184 results

Search Page

Filters